XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 14.37%775.4M | 14.37%775.4M | 20.83%756.95M | 21.96%735.36M | 23.52%744.62M | 16.45%677.95M | 16.45%677.95M | 12.26%626.48M | 7.06%602.96M | 2.71%602.81M |
-Cash and cash equivalents | 22.34%437.72M | 22.34%437.72M | 38.01%439.3M | 13.99%356.24M | 30.00%427.66M | 20.58%357.79M | 20.58%357.79M | 20.29%318.32M | -44.51%312.52M | -43.95%328.96M |
-Short-term investments | 5.47%337.67M | 5.47%337.67M | 3.08%317.65M | 30.53%379.12M | 15.75%316.96M | 12.14%320.16M | 12.14%320.16M | 5.02%308.16M | --290.45M | --273.85M |
Receivables | 19.27%246.47M | 19.27%246.47M | 18.99%173.39M | 26.38%158.7M | 30.90%139M | 38.98%206.64M | 38.98%206.64M | 36.50%145.71M | 40.66%125.58M | 33.11%106.19M |
-Accounts receivable | 19.27%246.47M | 19.27%246.47M | 18.99%173.39M | 26.38%158.7M | 30.90%139M | 38.98%206.64M | 38.98%206.64M | 36.50%145.71M | 40.66%125.58M | 33.11%106.19M |
Current deferred assets | 18.12%33.92M | 18.12%33.92M | 20.61%32.15M | 20.62%30.95M | 22.29%29.62M | 21.69%28.72M | 21.69%28.72M | 29.03%26.66M | 33.27%25.66M | 31.93%24.22M |
Other current assets | 10.82%47.01M | 10.82%47.01M | 25.88%54.25M | -5.12%41.47M | -0.17%41.71M | -5.16%42.42M | -5.16%42.42M | -13.66%43.1M | -0.84%43.71M | 2.57%41.78M |
Total current assets | 15.39%1.1B | 15.39%1.1B | 20.76%1.02B | 21.13%966.48M | 23.22%954.94M | 19.58%955.73M | 19.58%955.73M | 14.49%841.95M | 11.47%797.91M | 6.78%774.99M |
Non current assets | ||||||||||
Net PPE | -9.29%104.11M | -9.29%104.11M | -15.73%101.02M | -8.69%103.2M | -9.17%105.86M | -2.86%114.77M | -2.86%114.77M | -3.03%119.88M | -11.52%113.03M | -7.68%116.55M |
-Gross PPE | -30.48%104.11M | -30.48%104.11M | -15.73%101.02M | -8.69%103.2M | -9.17%105.86M | 3.93%149.76M | 3.93%149.76M | -3.03%119.88M | -11.52%113.03M | -7.68%116.55M |
-Accumulated depreciation | ---- | ---- | ---- | ---- | ---- | -34.85%-34.99M | -34.85%-34.99M | ---- | ---- | ---- |
Goodwill and other intangible assets | 3.02%782.92M | 3.02%782.92M | 3.18%784.42M | 4.53%788.42M | -0.29%755.29M | -0.09%759.95M | -0.09%759.95M | -0.32%760.27M | -1.33%754.27M | -1.29%757.49M |
-Goodwill | 1.91%549.65M | 1.91%549.65M | 2.06%550.22M | 2.04%550.36M | 0.00%539.13M | 0.04%539.35M | 0.04%539.35M | 0.02%539.11M | -0.04%539.36M | -0.17%539.13M |
-Other intangible assets | 5.75%233.27M | 5.75%233.27M | 5.90%234.2M | 10.77%238.06M | -1.01%216.16M | -0.42%220.59M | -0.42%220.59M | -1.13%221.16M | -4.41%214.91M | -3.98%218.36M |
Investments and advances | --46.04M | --46.04M | --52.28M | --45.43M | ---- | ---- | ---- | ---- | ---- | ---- |
Non current deferred assets | 6.60%47.51M | 6.60%47.51M | 5.59%44.59M | 4.94%44.19M | 8.58%43.76M | 10.10%44.56M | 10.10%44.56M | 25.96%42.23M | 38.54%42.11M | 40.24%40.3M |
Other non current assets | 12.76%20.92M | 12.76%20.92M | 5.37%19.69M | 3.63%19.32M | -13.66%18.87M | -15.30%18.55M | -15.30%18.55M | -15.43%18.68M | -20.91%18.64M | -9.26%21.86M |
Total non current assets | 6.79%1B | 6.79%1B | 6.48%1B | 7.81%1B | -1.33%923.77M | -0.36%937.83M | -0.36%937.83M | -0.09%941.06M | -1.91%928.05M | -1.09%936.19M |
Total assets | 11.13%2.1B | 11.13%2.1B | 13.22%2.02B | 13.97%1.97B | 9.79%1.88B | 8.80%1.89B | 8.80%1.89B | 6.30%1.78B | 3.85%1.73B | 2.33%1.71B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | 173.73%36.07M | 173.73%36.07M | 47.87%25.01M | 73.44%26.95M | -15.45%16.45M | -7.74%13.18M | -7.74%13.18M | 3.90%16.91M | -26.88%15.54M | 35.00%19.45M |
-accounts payable | 173.73%36.07M | 173.73%36.07M | 47.87%25.01M | 73.44%26.95M | -15.45%16.45M | -7.74%13.18M | -7.74%13.18M | 3.90%16.91M | -26.88%15.54M | 35.00%19.45M |
Current accrued expenses | 6.17%88.74M | 6.17%88.74M | -4.20%78.57M | 26.00%58.72M | -6.35%56.29M | 6.08%83.58M | 6.08%83.58M | 67.12%82.02M | 58.21%46.6M | 40.77%60.1M |
Current deferred liabilities | 16.50%584.72M | 16.50%584.72M | 17.86%501.6M | 18.69%494.68M | 21.07%487.94M | 26.57%501.9M | 26.57%501.9M | 29.33%425.59M | 31.66%416.79M | 30.00%403.01M |
Other current liabilities | -21.44%21.43M | -21.44%21.43M | 30.36%31.19M | 16.11%31.89M | 4.37%23.59M | 26.05%27.28M | 26.05%27.28M | -21.50%23.92M | -6.76%27.47M | -10.74%22.6M |
Current liabilities | 13.78%730.96M | 13.78%730.96M | 15.58%649.02M | 20.18%624.78M | 15.60%594.98M | 20.84%642.43M | 20.84%642.43M | 22.37%561.56M | 23.97%519.89M | 25.96%514.69M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | -9.15%74.05M | -9.15%74.05M | -13.33%73.92M | -6.43%75.05M | -6.79%76.77M | -2.58%81.5M | -2.58%81.5M | -0.51%85.29M | -10.10%80.2M | -9.27%82.36M |
-Long term capital lease obligation | -9.15%74.05M | -9.15%74.05M | -13.33%73.92M | -6.43%75.05M | -6.79%76.77M | -2.58%81.5M | -2.58%81.5M | -0.51%85.29M | -10.10%80.2M | -9.27%82.36M |
Non current deferred liabilities | -24.40%5.82M | -24.40%5.82M | -17.37%4.82M | 19.24%6.14M | 33.72%7.4M | 45.74%7.69M | 45.74%7.69M | 16.19%5.84M | 30.48%5.15M | 32.89%5.54M |
Other non current liabilities | -19.11%5.12M | -19.11%5.12M | -18.98%5.32M | 23.23%5.28M | 38.42%5.88M | 107.67%6.33M | 107.67%6.33M | 96.03%6.57M | 24.33%4.28M | -1.85%4.25M |
Total non current liabilities | -11.04%84.99M | -11.04%84.99M | -13.95%84.07M | -3.54%86.46M | -2.27%90.05M | 3.84%95.53M | 3.84%95.53M | 3.82%97.7M | -7.21%89.63M | -7.17%92.14M |
Total liabilities | 10.57%815.94M | 10.57%815.94M | 11.20%733.09M | 16.69%711.24M | 12.89%685.03M | 18.33%737.96M | 18.33%737.96M | 19.21%659.25M | 18.13%609.52M | 19.48%606.83M |
Shareholders'equity | ||||||||||
Share capital | 0.00%15K | 0.00%15K | 7.14%15K | 7.14%15K | 7.14%15K | 7.14%15K | 7.14%15K | 0.00%14K | 0.00%14K | 7.69%14K |
-common stock | 0.00%15K | 0.00%15K | 7.14%15K | 7.14%15K | 7.14%15K | 7.14%15K | 7.14%15K | 0.00%14K | 0.00%14K | 7.69%14K |
-Preferred stock | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | -9.30%-1.24B | -9.30%-1.24B | -6.60%-1.18B | -8.51%-1.16B | -13.55%-1.15B | -19.99%-1.14B | -19.99%-1.14B | -26.35%-1.11B | -32.07%-1.07B | -38.02%-1.01B |
Paid-in capital | 10.46%2.54B | 10.46%2.54B | 10.42%2.47B | 10.55%2.41B | 10.69%2.35B | 11.00%2.3B | 11.00%2.3B | 11.50%2.24B | 11.78%2.18B | 11.63%2.12B |
Gains losses not affecting retained earnings | -99.05%-2.74M | -99.05%-2.74M | 87.05%-314K | -16.29%-2.33M | -2.99%-2.07M | 40.63%-1.38M | 40.63%-1.38M | 11.79%-2.43M | -94.46%-2M | -743.70%-2.01M |
Total stockholders'equity | 11.49%1.29B | 11.49%1.29B | 14.41%1.29B | 12.48%1.26B | 8.09%1.19B | 3.48%1.16B | 3.48%1.16B | -0.05%1.12B | -2.58%1.12B | -5.16%1.1B |
Total equity | 11.49%1.29B | 11.49%1.29B | 14.41%1.29B | 12.48%1.26B | 8.09%1.19B | 3.48%1.16B | 3.48%1.16B | -0.05%1.12B | -2.58%1.12B | -5.16%1.1B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |